Unveiling the therapeutic potential of HZQYF: exploring the inhibitory impact of a clinical herbal formula on gastric cancer through network pharmacology and transcript analysis.

Hezi Qingyou Formula (HZQYF) is a clinical formulation known for its efficacy in treating gastrointestinal diseases. Nevertheless, its specific impact and underlying mechanism of action in gastric cancer remain to be fully elucidated. The major components of the formula were precisely identified and...

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Complementary Medicine & Therapies Vol. 25; no. 1; pp. 1 - 14
Autores principales: Feng, Zhong, Ou, Ling, Li, Hui, Hao, Yajie, Wei, Ruixia, Zhang, Guimin, Yao, Meicun
Formato: pictorial research tables/charts Journal Article
Publicado: BioMed Central 4/17/2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184555967&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 184555967
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        26627671
        MFH8
      jtl: BMC Complementary Medicine & Therapies
      issn: 26627671
      maglogo: N
    pubinfo:
      dt: 4/17/2025
      vid: 25
      iid: 1
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        184555967
        184555967
        184555967
        10.1186/s12906-025-04871-5
        184555967
      ppf: 1
      ppct: 13
      formats:
      tig:
        atl: Unveiling the therapeutic potential of HZQYF: exploring the inhibitory impact of a clinical herbal formula on gastric cancer through network pharmacology and transcript analysis.
      aug:
        au:
          Feng, Zhong
          Ou, Ling
          Li, Hui
          Hao, Yajie
          Wei, Ruixia
          Zhang, Guimin
          Yao, Meicun
        affil: https://ror.org/0064kty71 School of Pharmaceutical Sciences (Shenzhen), Sun Yat-Sen University, 518107, Shenzhen, China
      sug:
        subj:
          Drugs, Chinese Herbal Pharmacodynamics
          Stomach Neoplasms Drug Therapy
          Network Pharmacology
          Funding Source
          Human
          Chromatography, High Pressure Liquid
          Liquid Chromatography-Mass Spectrometry
          In Vitro Studies
          Cell Viability Drug Effects
          Cell Line, Tumor Drug Effects
          Reactive Oxygen Species Drug Effects
          Phytochemicals Analysis
          T-Tests
          Data Analysis Software
          Descriptive Statistics
          Signal Transduction Drug Effects
          Nitrogen Metabolism
          GABA Metabolism
      ab: Hezi Qingyou Formula (HZQYF) is a clinical formulation known for its efficacy in treating gastrointestinal diseases. Nevertheless, its specific impact and underlying mechanism of action in gastric cancer remain to be fully elucidated. The major components of the formula were precisely identified and characterized using ultra-high-performance liquid chromatography coupled with a tandem mass spectrometer (UHPLC-MS/MS). Network pharmacology and transcript analysis were utilized to identify the targets associated with drug-disease interactions. Subsequently, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Reactome analyses were conducted to unravel the pivotal pathways involved. Furthermore, in vitro experiments were performed to validate the anti-gastric cancer activity of HZQYF, including assessments of cell viability and clonogenic potential. These results revealed that 260 co-expressed targets were identified as shared between HZQYF and gastric cancer. These genes were significantly enriched in biological processes and pathways related to steroid metabolism, gamma-aminobutyric acid (GABA)-A receptor complex, steroid binding activity, extracellular ligand-gated ion channel activity, chemical carcinogenesis-reactive oxygen species, and GABAergic synapse. Furthermore, the principal components of the formula were characterized. Subsequent cell experiments confirmed the formula's ability to inhibit gastric cancer activity and suppress colony formation in vitro. In conclusion, these findings suggest that Hezi Qingyou Formula may exert its anti-gastric cancer activity by influencing reactive oxygen species and modulating GABAergic synapses in-silico methods. This study provides a foundation for further exploration of HZQYF as a potential therapeutic agent for gastric cancer.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N